ZTS Q4 2021 Earnings — Zoetis Inc. Revenue & Financial Results | Market Cap Arena

ZTSZoetis Inc.

$54B

Q4 2021 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$2.0B+8.9% YoY

Gross Profit

$1.3B67.5% margin

Operating Income

$596M30.3% margin

Net Income

$414M21.0% margin

EPS (Diluted)

$0.87

QoQ Revenue Growth

-1.2%

Cash Flow

Operating Cash Flow

$679M

Free Cash Flow

$511M

Stock-Based Comp.

$14M

Balance Sheet

Total Assets

$13.9B

Total Liabilities

$9.4B

Stockholders' Equity

$4.5B

Cash & Equivalents

$3.5B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2.0B	$1.8B	+8.9%
Gross Profit	$1.3B	$1.2B	+13.8%
Operating Income	$596M	$513M	+16.2%
Net Income	$414M	$359M	+15.3%

Revenue Segments

Horses

$4.2B85%

Cattle

$413M8%

Swine

$155M3%

Poultry

$118M2%

Fish

$55M1%

Geographic Segments

United States Segment

$1.0B54%

International Segment

$902M46%